RSPO2 and Parkinson disease: The PD array database profiling indicates that tissue of the substantia nigra has reduced RSPO2 and elevated NR0B1 (and NEUROD1) leading us to believe that dysregulation of β-catenin-dependent WNT signalling is evident in the substantia nigra of individuals with PD.